Upgrade to SI Premium - Free Trial

Coherus Oncology (CHRS)

1.02 +0.02 (2.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026 October 14, 2026 4:30 PM - StreetInsider Coherus Oncology hires Oppenheimer to sell biosimilar assets September 23, 2026 9:31 AM - StreetInsider Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets September 23, 2026 9:30 AM - Globe NewsWire Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets September 23, 2026 9:30 AM - StreetInsider Coherus to Participate in Upcoming Investor Conferences August 31, 2026 9:30 AM - StreetInsider Form 8-K Coherus Oncology, Inc. For: Aug 28 August 28, 2026 5:12 PM - SEC Filing Form 424B5 Coherus Oncology, Inc. August 28, 2026 4:35 PM - SEC Filing Form 424B3 Coherus Oncology, Inc. August 28, 2026 4:33 PM - SEC Filing Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights August 17, 2026 5:33 PM - Globe NewsWire Form 8-K Coherus Oncology, Inc. For: Aug 17 August 17, 2026 5:28 PM - SEC Filing Form 8-K Coherus Oncology, Inc. For: Aug 17 August 17, 2026 5:28 PM - SEC Filing Coherus BioSciences (CHRS) Tops Q2 EPS by 7c August 5, 2026 5:49 PM - StreetInsider Form S-8 Coherus Oncology, Inc. August 5, 2026 5:24 PM - SEC Filing Form 10-Q Coherus Oncology, Inc. For: Jun 30 August 5, 2026 5:14 PM - SEC Filing Form 8-K Coherus Oncology, Inc. For: Aug 05 August 5, 2026 4:44 PM - SEC Filing Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update August 5, 2026 4:28 PM - Globe NewsWire Form SCHEDULE 13G Coherus Oncology, Inc. Filed by: BlackRock, Inc. July 27, 2026 4:26 PM - SEC Filing Full Article List